Same place as ever, impressions and click-through. The theoretical goal here would be to offload all the processing to the user’s PC, making delivery of this customized ad content close to free.
However the largest advertising targets are now mobile by far, and those platforms don’t have GPU to speak of, especially from an AI perspective. So so far not feasible.
So uh yeah as we all know a lot of amphetamines have already been “open source” for a long time.
And we also know the DEA really doesn’t approve of private production… Vyvanse itself only really was created as a produg because of their control of the amphetamine market and their desire for products with lower abuse potential.
If we could get the DEA out of the way anyways, it would make more sense to just make dextroamphetamine as it’s simple, cheap and effective.